AI40882/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2000	2
2002	1
2003	2
2004	1
2005	1
2006	3
2007	1
2010	2
2024	0

1

Kutilek VD, Sheeter DA, Elder JH, Torbett BE. Kutilek VD, et al. Curr Drug Targets Infect Disord. 2003 Dec;3(4):295-309. doi: 10.2174/1568005033481079. Curr Drug Targets Infect Disord. 2003. PMID: 14754431 Review.

2

Defining HIV-1 protease substrate selectivity.

Beck ZQ, Morris GM, Elder JH. Beck ZQ, et al. Curr Drug Targets Infect Disord. 2002 Mar;2(1):37-50. doi: 10.2174/1568005024605837. Curr Drug Targets Infect Disord. 2002. PMID: 12462152 Review.

3

Can gene delivery close the door to HIV-1 entry after escape?

Swan CH, Torbett BE. Swan CH, et al. J Med Primatol. 2006 Aug;35(4-5):236-47. doi: 10.1111/j.1600-0684.2006.00172.x. J Med Primatol. 2006. PMID: 16872287 Review.

4

T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.

Swan CH, Bühler B, Steinberger P, Tschan MP, Barbas CF 3rd, Torbett BE. Swan CH, et al. Gene Ther. 2006 Oct;13(20):1480-92. doi: 10.1038/sj.gt.3302801. Epub 2006 Jun 1. Gene Ther. 2006. PMID: 16738691

5

Feline immunodeficiency virus Vif localizes to the nucleus.

Chatterji U, Grant CK, Elder JH. Chatterji U, et al. J Virol. 2000 Mar;74(6):2533-40. doi: 10.1128/jvi.74.6.2533-2540.2000. J Virol. 2000. PMID: 10684267 Free PMC article.

6

Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3.

Heaslet H, Lin YC, Tam K, Torbett BE, Elder JH, Stout CD. Heaslet H, et al. Retrovirology. 2007 Jan 9;4:1. doi: 10.1186/1742-4690-4-1. Retrovirology. 2007. PMID: 17212810 Free PMC article.

7

Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.

Beck ZQ, Hervio L, Dawson PE, Elder JH, Madison EL. Beck ZQ, et al. Virology. 2000 Sep 1;274(2):391-401. doi: 10.1006/viro.2000.0420. Virology. 2000. PMID: 10964781 Free article.

8

Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and Vina.

Chang MW, Ayeni C, Breuer S, Torbett BE. Chang MW, et al. PLoS One. 2010 Aug 4;5(8):e11955. doi: 10.1371/journal.pone.0011955. PLoS One. 2010. PMID: 20694138 Free PMC article.

9

Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3.

Heaslet H, Kutilek V, Morris GM, Lin YC, Elder JH, Torbett BE, Stout CD. Heaslet H, et al. J Mol Biol. 2006 Mar 3;356(4):967-81. doi: 10.1016/j.jmb.2005.11.094. Epub 2005 Dec 20. J Mol Biol. 2006. PMID: 16403521

10

Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3.

de Rozières S, Swan CH, Sheeter DA, Clingerman KJ, Lin YC, Huitron-Resendiz S, Henriksen S, Torbett BE, Elder JH. de Rozières S, et al. Retrovirology. 2004 Nov 19;1:38. doi: 10.1186/1742-4690-1-38. Retrovirology. 2004. PMID: 15555065 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year